speb/financial-data huggingface dataset:
Financial ratios for JWL.NS — annual report dated 2025-03-31
Total revenue: 463324701.8938508
Gross profit: 100206137.47954173
Operating income: 61244669.160626605
Net income: 44687748.42179097
Capital expenditures: 59291758.241758235
Operating cash flow: 12180827.682955341
Depreciation & amortization: 6270668.693009118
Net tangible assets: 297515934.06593406
Owner earnings: -8333341.126958147
Return on net tangible assets (%): -2.8009730480893675
Capex to operating income (%): 96.81129648403119
Buffett classification: The Gruesome
Stock price: 4.298517913408799
P/E ratio: 41.1087901640886
Shares outstanding: 427370389
Book value: 323542599.95323825
P/B ratio: 5.677951753625327
Market cap (USD): 1837059272.7769866
Debt to equity: 0.18124975023336243
Current ratio: 2.2038652124674405
Quick ratio: 1.540949843085167
Effective tax rate (%): 23.31760580790533
Interest coverage ratio: 8.670078626786728
COGS to revenue (%): 78.37237318236072
SG&A to revenue (%): 1.1261835053520701
Free cash flow (dilution-adjusted): -47223673.13537526
Buyback yield (%): 0
Inventory turnover: 4.0370671037869545
Receivables turnover: 4.863737814054365
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.45658635648962
FCF margin (%): -10.19234954284703
Revenue growth (%): 6.035880537492184
Rule of 40 score: -4.156469005354846
Financial ratios for JWL.NS — quarterly report dated 2025-06-30
Total revenue: 53749450.03510415
Gross profit: 14223788.907091038
Operating income: 5101170.138076293
Net income: 3826538.731570326
Capital expenditures: 0
Owner earnings: 3826538.731570326
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.544816288322022
P/E ratio: 71.291631487272
Shares outstanding: 427370389
Market cap (USD): 1942319905.0737188
Effective tax rate (%): 29.301251422070536
Interest coverage ratio: 2.7347983463712384
COGS to revenue (%): 73.53686614876733
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -55.98355196222432
Rule of 40 score: -55.98355196222432
Financial ratios for JWL.NS — quarterly report dated 2025-09-30
Total revenue: 88595885.00563698
Gross profit: 19869582.86358512
Operating income: 9825749.71815107
Net income: 5249075.535512965
Capital expenditures: 0
Net tangible assets: 291768286.3585118
Owner earnings: 5249075.535512965
Return on net tangible assets (%): 1.799056230896574
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.782976324689966
P/E ratio: 49.75511412842515
Shares outstanding: 427370389
Book value: 315818376.5501691
P/B ratio: 5.119182997268419
Market cap (USD): 1616732063.4605412
Debt to equity: 0.26721218544616104
Current ratio: 2.095582597246725
Quick ratio: 1.1972985872355457
Effective tax rate (%): 33.22953277966491
Interest coverage ratio: 4.679481121944933
COGS to revenue (%): 77.57279261636035
Buyback yield (%): 0
Inventory turnover: 0.5448183333537401
Receivables turnover: 1.4000085157205904
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.014151965420101
Revenue growth (%): 64.83124003645501
Rule of 40 score: 64.83124003645501
Financial ratios for JWL.NS — quarterly report dated 2025-12-31
Total revenue: 99182811.6297204
Gross profit: 21958126.322825
Operating income: 11059619.026400803
Net income: 7017344.324384538
Capital expenditures: 0
Owner earnings: 7017344.324384538
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.784671939400691
P/E ratio: 57.42790706016285
Shares outstanding: 427370389
Market cap (USD): 1617456718.9790578
Effective tax rate (%): 28.186006334581055
Interest coverage ratio: 5.378263154188268
COGS to revenue (%): 77.8609559841867
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.94968211380227
Rule of 40 score: 11.94968211380227
Financial ratios for KIOCL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Depreciation & amortization: 4112132.4014242385
Buffett classification: The Gruesome
Stock price: 2.7417908479493605
Shares outstanding: 607751096
Market cap (USD): 1666326392.8439932
Buyback yield (%): 0
Retained earnings: 61697125.14835817
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KIOCL.NS — annual report dated 2023-03-31
Total revenue: 187966321.5590743
Gross profit: 31603191.230207067
Operating income: -21973459.196102317
Net income: -11896102.314250914
Capital expenditures: 8630767.356881851
Operating cash flow: -37681437.271619976
Depreciation & amortization: 3075822.168087698
Net tangible assets: 242677539.5858709
Owner earnings: -17451047.503045067
Return on net tangible assets (%): -7.191043527483125
Buffett classification: The Gruesome
Stock price: 2.0529841656516448
Shares outstanding: 607751096
Book value: 243853434.8355664
P/B ratio: 5.11661185985252
Market cap (USD): 1247703376.7454326
Debt to equity: 0.26839692798838305
Current ratio: 2.6488206142185384
Quick ratio: 2.179594774058442
Interest coverage ratio: -13.226736172209515
COGS to revenue (%): 83.18677996777484
SG&A to revenue (%): 0.13974177741302427
Free cash flow (dilution-adjusted): -89242399.5127893
Buyback yield (%): 0
Retained earnings: 39241169.305724725
Inventory turnover: 3.8529430832037255
Receivables turnover: 4.35657521794119
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.097142859451171
FCF margin (%): -47.47786665854504
Rule of 40 score: -47.47786665854504
Financial ratios for KIOCL.NS — annual report dated 2024-03-31
Total revenue: 222337306.6314906
Gross profit: 46549826.1182396
Operating income: -11971459.40760283
Net income: -9989830.914977815
Capital expenditures: 11122556.6614702
Operating cash flow: 12558520.206259742
Depreciation & amortization: 3288212.0158292362
Net tangible assets: 166395814.8459048
Owner earnings: -17824175.56061878
Return on net tangible assets (%): -10.711913383834398
Buffett classification: The Gruesome
Stock price: 4.665307101727447
Shares outstanding: 607751096
Book value: 230063964.5041372
P/B ratio: 12.324161718948611
Market cap (USD): 2835345504.2514396
Debt to equity: 0.09357205204848737
Current ratio: 4.409432432666673
Quick ratio: 2.8625026083976737
Interest coverage ratio: -6.999032488747424
COGS to revenue (%): 78.29905956126379
SG&A to revenue (%): 0.09183575945427759
Free cash flow (dilution-adjusted): -1019402.8060918575
Buyback yield (%): 0
Retained earnings: 28644297.87744334
Inventory turnover: 3.128251816815442
Receivables turnover: 240.85410306707024
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.668873816003439
FCF margin (%): -0.45849381803542777
Revenue growth (%): 18.28571458297869
Rule of 40 score: 17.827220764943263
Financial ratios for KIOCL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1186096.5121834688
Net tangible assets: 150121691.35212615
Buffett classification: The Gruesome
Stock price: 4.707357859531773
Shares outstanding: 607751096
Book value: 214560475.39417106
P/B ratio: 13.333778708025601
Market cap (USD): 2860901898.394649
Debt to equity: 0.12144049633571846
Current ratio: 4.206265849436204
Quick ratio: 2.7716198942591115
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KIOCL.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 1246065.9750553677
Buffett classification: The Gruesome
Stock price: 4.666044993588996
Shares outstanding: 607751096
Market cap (USD): 2835793958.8390255
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KIOCL.NS — quarterly report dated 2025-03-31
Total revenue: 28841477.6712649
Gross profit: 8044189.8527004905
Operating income: -6036941.781622632
Net income: -4311433.24760346
Capital expenditures: 0
Depreciation & amortization: 1263736.2637362636
Net tangible assets: 136916074.35118073
Owner earnings: -3047696.9838671964
Return on net tangible assets (%): -2.225959952700699
Buffett classification: The Gruesome
Stock price: 2.763099544871047
Shares outstanding: 607751096
Book value: 200082253.91629645
P/B ratio: 8.392932126079499
Market cap (USD): 1679276776.75248
Debt to equity: 0.11294554098513143
Current ratio: 3.5550669710526597
Quick ratio: 3.1702072362378177
Interest coverage ratio: -14.10928961748634
COGS to revenue (%): 72.10895383243484
Buyback yield (%): 0
Retained earnings: 4007727.3790039746
Inventory turnover: 1.4923770487677612
Receivables turnover: 9.30149262734837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.609829525672581
Rule of 40 score: 0
Financial ratios for KIOCL.NS — annual report dated 2025-03-31
Total revenue: 69027355.6231003
Gross profit: 9188683.656768762
Operating income: -28048866.02758943
Net income: -23916296.469487958
Capital expenditures: 2767032.9670329667
Operating cash flow: 40139057.75075988
Depreciation & amortization: 4618400.748187982
Net tangible assets: 136916074.35118073
Owner earnings: -22064928.68833294
Return on net tangible assets (%): -16.115659752073995
Buffett classification: The Gruesome
Stock price: 2.763099544871047
Shares outstanding: 607751096
Book value: 200082253.91629645
P/B ratio: 8.392932126079499
Market cap (USD): 1679276776.75248
Debt to equity: 0.11294554098513143
Current ratio: 3.5550669710526597
Quick ratio: 3.1702072362378177
Interest coverage ratio: -15.73311475409836
COGS to revenue (%): 86.68834468041867
SG&A to revenue (%): 0.3386173491853809
Free cash flow (dilution-adjusted): 36943172.78466214
Buyback yield (%): 0
Retained earnings: 4007727.3790039746
Inventory turnover: 4.293918584498405
Receivables turnover: 22.26160000301617
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.125801667208021
FCF margin (%): 53.519611828066246
Revenue growth (%): -68.9537681872217
Rule of 40 score: -15.434156359155452
Financial ratios for KIOCL.NS — quarterly report dated 2025-06-30
Total revenue: 10638895.38965598
Gross profit: 5462204.540135737
Operating income: -6084717.996723614
Net income: -4421951.790311257
Capital expenditures: 0
Owner earnings: -4421951.790311257
Buffett classification: The Gruesome
Stock price: 3.512169435993447
Shares outstanding: 607751096
Market cap (USD): 2134524824.0627193
Interest coverage ratio: -14.285714285714285
COGS to revenue (%): 48.65816102067752
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -63.11251624858447
Rule of 40 score: -63.11251624858447
Financial ratios for KIOCL.NS — quarterly report dated 2025-09-30
Total revenue: 16069898.53438557
Gross profit: 11553551.296505073
Operating income: -2281848.9289740697
Net income: -1934611.0484780157
Capital expenditures: 0
Depreciation & amortization: 1109357.3844419392
Net tangible assets: 126057237.88049605
Owner earnings: -825253.6640360765
Return on net tangible assets (%): -0.6546658311031914
Buffett classification: The Gruesome
Stock price: 4.785231116121759
Shares outstanding: 607751096
Book value: 186987474.63359636
P/B ratio: 15.553070926996602
Market cap (USD): 2908229455.436302
Debt to equity: 0.11137926570752832
Current ratio: 3.5138817262539193
Quick ratio: 3.2034111828908447
Interest coverage ratio: -5.56043956043956
COGS to revenue (%): 28.1043917496843
Buyback yield (%): 0
Inventory turnover: 0.4398017269298964
Receivables turnover: 2.754023610332902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0573685106880941
Revenue growth (%): 51.0485623348648
Rule of 40 score: 51.0485623348648
Financial ratios for KIOCL.NS — quarterly report dated 2025-12-31
Total revenue: 17784337.752032973
Gross profit: 14410159.295978613
Operating income: 114737.66291634177
Net income: 2019605.6589060933
Capital expenditures: 0
Depreciation & amortization: 1070513.5345883926
Owner earnings: 3090119.1934944857
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.473097916898742
P/E ratio: 336.5174470474352
Shares outstanding: 607751096
Market cap (USD): 2718530161.510527
Effective tax rate (%): -38.080731150038076
Interest coverage ratio: 0.28296703296703296
COGS to revenue (%): 18.972752896962106
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 10.66863747757294
Rule of 40 score: 10.66863747757294
Financial ratios for KVYO — annual report dated 2023-12-31
Total revenue: 698099000
Gross profit: 520211000
Operating income: -330622000
Net income: -308233000
Capital expenditures: 3653000
Operating cash flow: 119371000
Depreciation & amortization: 13651000
Net tangible assets: 914777000
Owner earnings: -298235000
Return on net tangible assets (%): -32.60193467916224
Buffett classification: The Gruesome
Stock price: 27.78
Shares outstanding: 140897018
Book value: 914777000
P/B ratio: 4.278768661695692
Market cap (USD): 3914119160.04
Debt to equity: 0.05638423353451169
Current ratio: 6.151535799595762
Quick ratio: 6.151535799595762
COGS to revenue (%): 25.481772642562156
R&D to revenue (%): 37.55584809604369
SG&A to revenue (%): 84.32271067570646
Free cash flow (dilution-adjusted): -230786000
Buyback yield (%): 0
Retained earnings: -799043000
Receivables turnover: 30.2521667533368
Capitalized R&D asset: 331908590
ROCI (R&D-adjusted, %): -14.765820189401534
Rosenberg metric: 1.6861362260633954
FCF margin (%): -33.05920793469121
Revenue growth (%): 47.66831377393453
Rule of 40 score: 14.60910583924332
Financial ratios for KVYO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.38
Shares outstanding: 140897018
Market cap (USD): 4984936496.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KVYO — annual report dated 2024-12-31
Total revenue: 937464000
Gross profit: 716159000
Operating income: -84078000
Net income: -46142000
Capital expenditures: 5921000
Operating cash flow: 165955000
Depreciation & amortization: 17717000
Net tangible assets: 1033987000
Owner earnings: -34346000
Return on net tangible assets (%): -3.321705205191168
Buffett classification: The Gruesome
Stock price: 41.24
Shares outstanding: 140897018
Book value: 1033987000
P/B ratio: 5.619599687733018
Market cap (USD): 5810593022.320001
Debt to equity: 0.05168150083124836
Current ratio: 4.901367231468836
Quick ratio: 4.901367231468836
COGS to revenue (%): 23.60677316675627
R&D to revenue (%): 25.436603432238464
SG&A to revenue (%): 59.9252877977181
Free cash flow (dilution-adjusted): 13517000
Buyback yield (%): 0
Retained earnings: -845185000
Receivables turnover: 21.75342847198051
Capitalized R&D asset: 448463000
ROCI (R&D-adjusted, %): -3.1007741750652813
Rosenberg metric: 0.7473882148319647
FCF margin (%): 1.4418687010914553
Revenue growth (%): 34.288116728429635
Rule of 40 score: 35.72998542952109
Financial ratios for KVYO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.24
Shares outstanding: 140897018
Market cap (USD): 5810593022.320001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KVYO — quarterly report dated 2025-03-31
Total revenue: 279827000
Gross profit: 212127000
Operating income: -23750000
Net income: -14089000
Capital expenditures: 2685000
Operating cash flow: 14362000
Depreciation & amortization: 4781000
Net tangible assets: 1063932000
Owner earnings: -11993000
Return on net tangible assets (%): -1.1272336953865472
Buffett classification: The Gruesome
Stock price: 30.26
Shares outstanding: 140897018
Book value: 1063932000
P/B ratio: 4.007346112984664
Market cap (USD): 4263543764.6800003
Debt to equity: 0.09651932642311727
Current ratio: 5.223618429241173
Quick ratio: 5.223618429241173
COGS to revenue (%): 24.19351956744703
R&D to revenue (%): 24.782812237561064
SG&A to revenue (%): 59.51105504472406
Free cash flow (dilution-adjusted): -31706000
Buyback yield (%): 0
Retained earnings: -859274000
Receivables turnover: 5.190728820790592
Capitalized R&D asset: 69349000
ROCI (R&D-adjusted, %): 1.8370653148515543
FCF margin (%): -11.33057210347822
Rule of 40 score: -11.33057210347822
Financial ratios for KVYO — quarterly report dated 2025-06-30
Total revenue: 293117000
Gross profit: 221881000
Operating income: -31326000
Net income: -24281000
Capital expenditures: 2060000
Operating cash flow: 55725000
Depreciation & amortization: 3931000
Net tangible assets: 1096752000
Owner earnings: -22410000
Return on net tangible assets (%): -2.043306052781303
Buffett classification: The Gruesome
Stock price: 33.58
Shares outstanding: 140897018
Book value: 1096752000
P/B ratio: 4.31393958200213
Market cap (USD): 4731321864.44
Debt to equity: 0.09043703590237355
Current ratio: 4.952744364938223
Quick ratio: 4.952744364938223
COGS to revenue (%): 24.302923406011935
R&D to revenue (%): 24.72016293834885
SG&A to revenue (%): 61.66411364745136
Free cash flow (dilution-adjusted): 3014000
Buyback yield (%): 0
Retained earnings: -883555000
Receivables turnover: 4.981340176401611
Capitalized R&D asset: 118922830
ROCI (R&D-adjusted, %): -0.47109583193452387
Rosenberg metric: 0.1406509106115445
FCF margin (%): 1.028258340526138
Revenue growth (%): 4.749362999281699
Rule of 40 score: 5.777621339807837
Financial ratios for KVYO — quarterly report dated 2025-09-30
Total revenue: 310880000
Gross profit: 234737000
Operating income: -10836000
Net income: -426000
Capital expenditures: 2274000
Operating cash flow: 54760000
Depreciation & amortization: 4380000
Net tangible assets: 1142074000
Owner earnings: 1680000
Buffett classification: The Gruesome
Stock price: 27.69
Shares outstanding: 140897018
Book value: 1142074000
P/B ratio: 3.4160995070547098
Market cap (USD): 3901438428.42
Debt to equity: 0.09929741855606554
Current ratio: 4.879224780986123
Quick ratio: 4.879224780986123
COGS to revenue (%): 24.492730313947504
R&D to revenue (%): 23.374935666495112
SG&A to revenue (%): 55.61792331446217
Free cash flow (dilution-adjusted): 6618000
Buyback yield (%): 0
Retained earnings: -883981000
Receivables turnover: 5.07608908627784
Capitalized R&D asset: 144100700
ROCI (R&D-adjusted, %): -0.6991571103735301
Rosenberg metric: 0.1774244745304241
FCF margin (%): 2.1287956767884713
Revenue growth (%): 6.060037459444522
Rule of 40 score: 8.188833136232994
Financial ratios for KVYO — annual report dated 2025-12-31
Total revenue: 1234019000
Gross profit: 921496000
Operating income: -67758000
Net income: -31768000
Capital expenditures: 9485000
Operating cash flow: 218007000
Depreciation & amortization: 18598000
Net tangible assets: 1196560000
Owner earnings: -22655000
Return on net tangible assets (%): -1.8933442535267768
Buffett classification: The Gruesome
Stock price: 32.47
Shares outstanding: 140897018
Book value: 1196560000
P/B ratio: 3.823398888864746
Market cap (USD): 4574926174.46
Debt to equity: 0.10091261616634352
Current ratio: 4.2733344435271565
Quick ratio: 4.2733344435271565
COGS to revenue (%): 25.325623025253257
R&D to revenue (%): 23.598421094002607
SG&A to revenue (%): 56.566795162797334
Free cash flow (dilution-adjusted): 27511000
Buyback yield (%): 0
Retained earnings: -876953000
Receivables turnover: 20.325114471126923
Capitalized R&D asset: 537494940
ROCI (R&D-adjusted, %): -2.205898178672749
Rosenberg metric: 0.861099811707673
FCF margin (%): 2.229382205622442
Revenue growth (%): 31.633748069259195
Rule of 40 score: 33.863130274881634
Financial ratios for KVYO — quarterly report dated 2025-12-31
Total revenue: 350195000
Gross profit: 252751000
Operating income: -1846000
Net income: 7028000
Capital expenditures: 2466000
Operating cash flow: 93160000
Depreciation & amortization: 5506000
Net tangible assets: 1196560000
Owner earnings: 10068000
Return on net tangible assets (%): 0.8414120478705622
Buffett classification: The Gruesome
Stock price: 32.47
P/E ratio: 162.73926346257824
Shares outstanding: 140897018
Book value: 1196560000
P/B ratio: 3.823398888864746
Market cap (USD): 4574926174.46
Debt to equity: 0.10091261616634352
Current ratio: 4.2733344435271565
Quick ratio: 4.2733344435271565
Effective tax rate (%): 9.105018106570098
COGS to revenue (%): 27.825640000571113
R&D to revenue (%): 21.91150644640843
SG&A to revenue (%): 50.78998843501478
Free cash flow (dilution-adjusted): 49585000
Buyback yield (%): 0
Retained earnings: -876953000
Receivables turnover: 5.767944790328425
Capitalized R&D asset: 149332030
ROCI (R&D-adjusted, %): 0.06449296902187679
Rosenberg metric: 0.2478945340452469
FCF margin (%): 14.159254129841944
Revenue growth (%): 12.646358723623264
Rule of 40 score: 26.805612853465206
Financial ratios for LASR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.95
Shares outstanding: 56408709
Market cap (USD): 1350988580.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LASR — annual report dated 2022-12-31
Total revenue: 242058000
Gross profit: 50821000
Operating income: -51210000
Net income: -54579000
Capital expenditures: 21388000
Operating cash flow: -14542000
Depreciation & amortization: 15699000
Net tangible assets: 254428000
Owner earnings: -60268000
Return on net tangible assets (%): -23.687644441649507
Buffett classification: The Gruesome
Stock price: 10.14
Shares outstanding: 56408709
Book value: 270845000
P/B ratio: 2.111851092912921
Market cap (USD): 571984309.26
Debt to equity: 0.057634440362569
Current ratio: 6.690131044879972
Quick ratio: 4.730256291313927
COGS to revenue (%): 79.00461872774294
R&D to revenue (%): 22.21492369597369
SG&A to revenue (%): 19.936544134050514
Free cash flow (dilution-adjusted): -63019000
Buyback yield (%): 0
Retained earnings: -222634000
Inventory turnover: 2.828949704142012
Receivables turnover: 6.384564661198006
Capitalized R&D asset: 53773000
ROCI (R&D-adjusted, %): -4.40766607175991
FCF margin (%): -26.034669376760945
Rule of 40 score: -26.034669376760945
Financial ratios for LASR — annual report dated 2023-12-31
Total revenue: 209921000
Gross profit: 46113000
Operating income: -45949000
Net income: -41670000
Capital expenditures: 5339000
Operating cash flow: 10091000
Depreciation & amortization: 16030000
Net tangible assets: 240368000
Owner earnings: -30979000
Return on net tangible assets (%): -12.8881548292618
Buffett classification: The Gruesome
Stock price: 13.5
Shares outstanding: 56408709
Book value: 254419000
P/B ratio: 2.9931631344357146
Market cap (USD): 761517571.5
Debt to equity: 0.05565229011984168
Current ratio: 6.7340620420127015
Quick ratio: 5.141487542745481
Interest coverage ratio: -685.8059701492538
COGS to revenue (%): 78.03316485725583
R&D to revenue (%): 21.990653626840572
SG&A to revenue (%): 21.864892030811593
Free cash flow (dilution-adjusted): -21080000
Buyback yield (%): 0
Retained earnings: -264304000
Inventory turnover: 3.140490797546012
Receivables turnover: 5.303044082354427
Capitalized R&D asset: 82190910
ROCI (R&D-adjusted, %): -9.290877651088273
Rosenberg metric: -0.08755323303516635
FCF margin (%): -10.041872895041468
Revenue growth (%): -13.276570078245708
Rule of 40 score: -23.318442973287176
Financial ratios for LASR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.69
Shares outstanding: 56408709
Market cap (USD): 603009099.2099999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LASR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.49
Shares outstanding: 56408709
Market cap (USD): 591727357.41
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LASR — annual report dated 2024-12-31
Total revenue: 198548000
Gross profit: 33019000
Operating income: -61345000
Net income: -60792000
Capital expenditures: 7932000
Operating cash flow: -2359000
Depreciation & amortization: 17596000
Net tangible assets: 203243000
Owner earnings: -51128000
Return on net tangible assets (%): -25.15609393681455
Buffett classification: The Gruesome
Stock price: 10.49
Shares outstanding: 56408709
Book value: 216430000
P/B ratio: 2.734035750173266
Market cap (USD): 591727357.41
Debt to equity: 0.05605969597560412
Current ratio: 5.669315028479626
Quick ratio: 4.477552212647875
Interest coverage ratio: -584.2380952380952
COGS to revenue (%): 83.36976449019883
R&D to revenue (%): 22.718435844229106
SG&A to revenue (%): 24.80861051231944
Free cash flow (dilution-adjusted): -35252000
Buyback yield (%): 0
Retained earnings: -325096000
Inventory turnover: 4.057083333333333
Receivables turnover: 5.68986960882648
Capitalized R&D asset: 93781300
ROCI (R&D-adjusted, %): -19.584036943407664
Rosenberg metric: -0.2836470766631285
FCF margin (%): -17.754900578197716
Revenue growth (%): -5.417752392566728
Rule of 40 score: -23.172652970764446
Financial ratios for LASR — quarterly report dated 2025-03-31
Total revenue: 51668000
Gross profit: 13799000
Operating income: -9610000
Net income: -8093000
Capital expenditures: 2281000
Operating cash flow: -20000
Depreciation & amortization: 3670000
Net tangible assets: 199691000
Owner earnings: -6704000
Return on net tangible assets (%): -3.3571868536889498
Buffett classification: The Gruesome
Stock price: 7.77
Shares outstanding: 56408709
Book value: 212759000
P/B ratio: 2.060057007835156
Market cap (USD): 438295668.92999995
Debt to equity: 0.15332841383913254
Current ratio: 5.8060974625299355
Quick ratio: 4.627694211985039
Interest coverage ratio: -200.20833333333334
COGS to revenue (%): 73.2929472787799
R&D to revenue (%): 22.013625454826972
SG&A to revenue (%): 23.292947278779902
Free cash flow (dilution-adjusted): -8357000
Buyback yield (%): 0
Retained earnings: -333189000
Inventory turnover: 0.8647272395131642
Receivables turnover: 1.4123886064184572
Capitalized R&D asset: 11374000
ROCI (R&D-adjusted, %): -0.7673276383038048
FCF margin (%): -16.17442130525664
Rule of 40 score: -16.17442130525664
Financial ratios for LASR — quarterly report dated 2025-06-30
Total revenue: 61735000
Gross profit: 18457000
Operating income: -4236000
Net income: -3591000
Capital expenditures: 1950000
Operating cash flow: -1385000
Depreciation & amortization: 3415000
Net tangible assets: 203017000
Owner earnings: -2126000
Return on net tangible assets (%): -1.0472029435958565
Buffett classification: The Gruesome
Stock price: 19.68
Shares outstanding: 56408709
Book value: 216001000
P/B ratio: 5.139436359646483
Market cap (USD): 1110123393.12
Debt to equity: 0.14813357345567846
Current ratio: 5.63368639247706
Quick ratio: 4.412851689880937
Interest coverage ratio: -10.917525773195877
COGS to revenue (%): 70.10285899408764
R&D to revenue (%): 17.837531384141897
SG&A to revenue (%): 18.921195432088766
Free cash flow (dilution-adjusted): -10149000
Buyback yield (%): 0
Retained earnings: -336780000
Inventory turnover: 0.8961176105186872
Receivables turnover: 1.3896454698930782
Capitalized R&D asset: 18632580
ROCI (R&D-adjusted, %): -0.2500659977389076
Rosenberg metric: 0.409530508176543
FCF margin (%): -16.439620960557217
Revenue growth (%): 19.484013315785397
Rule of 40 score: 3.0443923552281795
Financial ratios for LASR — quarterly report dated 2025-09-30
Total revenue: 66742000
Gross profit: 20753000
Operating income: -5566000
Net income: -6874000
Capital expenditures: 2766000
Operating cash flow: 5217000
Depreciation & amortization: 3313000
Net tangible assets: 205609000
Owner earnings: -6327000
Return on net tangible assets (%): -3.0771999280187154
Buffett classification: The Gruesome
Stock price: 29.63
Shares outstanding: 56408709
Book value: 218493000
P/B ratio: 7.649627437354972
Market cap (USD): 1671390047.6699998
Debt to equity: 0.14329520854215008
Current ratio: 5.634161383427486
Quick ratio: 4.364777857266201
Interest coverage ratio: -17.558359621451103
COGS to revenue (%): 68.90563663060742
R&D to revenue (%): 17.281471936711515
SG&A to revenue (%): 22.152467711486022
Free cash flow (dilution-adjusted): -6915000
Buyback yield (%): 0
Retained earnings: -343654000
Inventory turnover: 0.8937365178692889
Receivables turnover: 1.3533264391589108
Capitalized R&D asset: 22665460
ROCI (R&D-adjusted, %): -1.901089278100992
Rosenberg metric: 0.20849981837994916
FCF margin (%): -10.360792304695694
Revenue growth (%): 8.110472179476796
Rule of 40 score: -2.2503201252188987
Financial ratios for LASR — annual report dated 2025-12-31
Total revenue: 261330000
Gross profit: 77963000
Operating income: -24202000
Net income: -23467000
Capital expenditures: 8490000
Operating cash flow: 21330000
Depreciation & amortization: 14257000
Net tangible assets: 214301000
Owner earnings: -17700000
Return on net tangible assets (%): -8.25941082869422
Buffett classification: The Gruesome
Stock price: 37.51
Shares outstanding: 56408709
Book value: 226749000
P/B ratio: 9.331422297738909
Market cap (USD): 2115890674.59
Debt to equity: 0.15967876374316975
Current ratio: 3.787593253072095
Quick ratio: 3.080396218480851
Interest coverage ratio: -22.326568265682656
COGS to revenue (%): 70.1668388627406
R&D to revenue (%): 18.356866796770365
SG&A to revenue (%): 20.737381854360386
Free cash flow (dilution-adjusted): -21113000
Buyback yield (%): 0
Retained earnings: -348563000
Inventory turnover: 4.03829805977052
Receivables turnover: 5.140648359430325
Capitalized R&D asset: 93427480
ROCI (R&D-adjusted, %): -6.574331052234402
Rosenberg metric: 0.9963863701864456
FCF margin (%): -8.079057130830751
Revenue growth (%): 31.620565304107824
Rule of 40 score: 23.541508173277073
Financial ratios for LASR — quarterly report dated 2025-12-31
Total revenue: 81185000
Gross profit: 24954000
Operating income: -4790000
Net income: -4909000
Capital expenditures: 1493000
Operating cash flow: 17518000
Depreciation & amortization: 3859000
Net tangible assets: 214301000
Owner earnings: -2543000
Return on net tangible assets (%): -1.1866486857270848
Buffett classification: The Gruesome
Stock price: 37.51
Shares outstanding: 56408709
Book value: 226749000
P/B ratio: 9.331422297738909
Market cap (USD): 2115890674.59
Debt to equity: 0.15967876374316975
Current ratio: 3.787593253072095
Quick ratio: 3.080396218480851
Interest coverage ratio: -14.471299093655588
COGS to revenue (%): 69.26279485126562
R&D to revenue (%): 17.308616123668166
SG&A to revenue (%): 19.32869372421014
Free cash flow (dilution-adjusted): 4308000
Buyback yield (%): 0
Retained earnings: -348563000
Inventory turnover: 1.2383773427004647
Receivables turnover: 1.5969981902588717
Capitalized R&D asset: 25413740
ROCI (R&D-adjusted, %): -1.0626466882336194
Rosenberg metric: 0.36422750130050285
FCF margin (%): 5.306398965326107
Revenue growth (%): 21.640046747175692
Rule of 40 score: 26.9464457125018
Financial ratios for LIB.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.659090909090909
Shares outstanding: 21222228
Market cap (USD): 35209605.54545454
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIB.MC — annual report dated 2022-12-31
Total revenue: 12247884.042553192
Gross profit: 6348168.085106383
Operating income: 2151641.4893617025
Net income: 1593523.4042553192
Capital expenditures: 117758.51063829788
Operating cash flow: -55687.234042553195
Depreciation & amortization: 298100
Net tangible assets: 95797597.87234043
Owner earnings: 1773864.8936170214
Return on net tangible assets (%): 1.8516799304100173
Capex to operating income (%): 5.4729615142916614
Buffett classification: The Great
Stock price: 1.0106382978723405
P/E ratio: 13.459479996154649
Shares outstanding: 21222228
Book value: 98235996.80851065
P/B ratio: 0.21833133555703466
Market cap (USD): 21447996.382978726
Debt to equity: 0.42343267440087856
Current ratio: 3.269243668588056
Quick ratio: 2.614941413649375
Effective tax rate (%): 30.572927505627955
Interest coverage ratio: 3.0922235098780875
COGS to revenue (%): 48.16926692765255
SG&A to revenue (%): 6.6834210442429
Free cash flow (dilution-adjusted): -197534.0425531915
Buyback yield (%): 0
Retained earnings: 1593523.4042553192
Inventory turnover: 0.41486290611917087
Receivables turnover: 46.178573290816836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5855785955501325
FCF margin (%): -1.6128013775023753
Rule of 40 score: -1.6128013775023753
Financial ratios for LIB.MC — annual report dated 2023-12-31
Total revenue: 14888006.666666666
Gross profit: 8459971.11111111
Operating income: 4911111.111111111
Net income: 2563333.3333333335
Capital expenditures: 220728.88888888888
Operating cash flow: 5281734.444444444
Depreciation & amortization: 333333.3333333333
Net tangible assets: 103868471.1111111
Owner earnings: 2675937.777777778
Return on net tangible assets (%): 2.576275311605627
Capex to operating income (%): 4.494479638009049
Buffett classification: The Great
Stock price: 1.0555555555555556
P/E ratio: 8.739105591677502
Shares outstanding: 21222228
Book value: 106162746.66666666
P/B ratio: 0.211008488099906
Market cap (USD): 22401240.666666668
Debt to equity: 0.36207390263452116
Current ratio: 7.215390490718344
Quick ratio: 6.015173236334094
Effective tax rate (%): 28.487290762554245
Interest coverage ratio: 3.2098765432098766
COGS to revenue (%): 43.17420002349393
SG&A to revenue (%): 7.670066420353565
Free cash flow (dilution-adjusted): 5061005.555555555
Buyback yield (%): 0
Retained earnings: 2563010
Inventory turnover: 0.5207148654507893
Receivables turnover: 58.568082874377126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1806261469863193
FCF margin (%): 33.9938426202269
Revenue growth (%): 21.555744771430042
Rule of 40 score: 55.54958739165694
Financial ratios for LIB.MC — annual report dated 2024-12-31
Total revenue: 8131250
Gross profit: 8134375
Operating income: 5480208.333333334
Net income: 2909375
Capital expenditures: 1898958.3333333335
Operating cash flow: -1680208.3333333335
Depreciation & amortization: 327083.3333333334
Net tangible assets: 99351310.41666667
Owner earnings: 1337500
Return on net tangible assets (%): 1.3462328724107375
Capex to operating income (%): 34.65120699486789
Buffett classification: The Good
Stock price: 1.84375
P/E ratio: 13.449102599355532
Shares outstanding: 21222228
Book value: 100950145.83333333
P/B ratio: 0.3876020440782755
Market cap (USD): 39128482.875
Debt to equity: 0.41850277994067625
Current ratio: 3.836438607208308
Quick ratio: 2.9347892486255347
Effective tax rate (%): 27.66122766122766
Interest coverage ratio: 2.9572793704328277
COGS to revenue (%): -0.03843197540353574
SG&A to revenue (%): 14.940635408660006
Free cash flow (dilution-adjusted): -3580208.3333333335
Buyback yield (%): 0.4472445317112234
Retained earnings: 2909613.541666667
Inventory turnover: -0.00016937669376693767
Receivables turnover: 7.623046874999999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.706911051947092
FCF margin (%): -44.03023315398411
Revenue growth (%): -45.383890657401636
Rule of 40 score: -89.41412381138575
Financial ratios for LIB.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 99351041.66666667
Buffett classification: The Gruesome
Stock price: 1.84375
Shares outstanding: 21222228
Book value: 100950145.83333333
P/B ratio: 0.3876020440782755
Market cap (USD): 39128482.875
Debt to equity: 0.41850277994067625
Current ratio: 3.836438607208308
Quick ratio: 2.9347892486255347
Buyback yield (%): 0
Retained earnings: 2909613.541666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIB.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 115905882.35294119
Buffett classification: The Gruesome
Stock price: 2.3058823529411763
Shares outstanding: 21222228
Book value: 116248235.29411766
P/B ratio: 0.4209608938276102
Market cap (USD): 48935961.035294116
Debt to equity: 0.2816892856058536
Buyback yield (%): 0
Retained earnings: -74669411.76470588
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LS4C.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 94
Shares outstanding: 486909949
Market cap (USD): 45769535206
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LS4C.DE — annual report dated 2022-12-31
Total revenue: 9328915662.650602
Gross profit: 8046987951.807229
Operating income: 1975903614.4578314
Net income: 1796385542.1686747
Capital expenditures: 48192771.08433735
Operating cash flow: 3297590361.445783
Depreciation & amortization: 2289156626.5060244
Net tangible assets: -10927710843.373495
Owner earnings: 4037349397.5903616
Return on net tangible assets (%): -36.94597574421169
Capex to operating income (%): 2.4390243902439024
Buffett classification: The Great
Shares outstanding: 486909949
Book value: 33916867469.879517
Debt to equity: 0.31341693012681615
Current ratio: 1.0016598260572602
Quick ratio: 1.0016598260572602
Effective tax rate (%): 21.112006446414185
Interest coverage ratio: 9.213483146067414
COGS to revenue (%): 13.741443884799173
SG&A to revenue (%): 5.4242541650523055
Free cash flow (dilution-adjusted): 1943373493.9759037
Retained earnings: 4626506024.096386
Receivables turnover: 7.591176470588234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.239150102101477
FCF margin (%): 20.831718971974688
Rule of 40 score: 20.831718971974688
Financial ratios for LS4C.DE — annual report dated 2023-12-31
Total revenue: 10606329113.92405
Gross profit: 9159493670.886076
Operating income: 2102531645.5696201
Net income: 1200000000
Capital expenditures: 154430379.74683544
Operating cash flow: 3724050632.911392
Depreciation & amortization: 2712658227.848101
Net tangible assets: -11822784810.126581
Owner earnings: 3758227848.101266
Return on net tangible assets (%): -31.788008565310495
Capex to operating income (%): 7.344972907886815
Buffett classification: The Great
Shares outstanding: 486909949
Book value: 32840506329.114014
Debt to equity: 0.37384366327474455
Current ratio: 1.0013804714680878
Quick ratio: 1.0013804714680878
Effective tax rate (%): 20.669456066945607
Interest coverage ratio: 5.848591549295775
COGS to revenue (%): 13.64124597207304
SG&A to revenue (%): 4.821577753908581
Free cash flow (dilution-adjusted): 2170886075.949367
Retained earnings: 3692405063.291139
Receivables turnover: 7.149317406143345
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.559178743961354
FCF margin (%): 20.467836257309944
Revenue growth (%): 13.693053913947578
Rule of 40 score: 34.16089017125752
Financial ratios for LS4C.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -12446250000
Buffett classification: The Gruesome
Shares outstanding: 486909949
Book value: 31441250000
Debt to equity: 0.39617540651214567
Current ratio: 1.0021635667985098
Quick ratio: 1.0021635667985098
Retained earnings: 2348750000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LS4C.DE — annual report dated 2024-12-31
Total revenue: 11072500000
Gross profit: 9606250000
Operating income: 1712500000
Net income: 1151250000
Capital expenditures: 92500000
Operating cash flow: 4245000000
Depreciation & amortization: 3102500000
Net tangible assets: -12446250000
Owner earnings: 4161250000
Return on net tangible assets (%): -33.43376519031837
Capex to operating income (%): 5.401459854014599
Buffett classification: The Great
Shares outstanding: 486909949
Book value: 31441250000
Debt to equity: 0.39617540651214567
Current ratio: 1.0021635667985098
Quick ratio: 1.0021635667985098
Effective tax rate (%): 26.788553259141494
Interest coverage ratio: 4.041297935103245
COGS to revenue (%): 13.242266877398961
Free cash flow (dilution-adjusted): 2782500000
Retained earnings: 2348750000
Receivables turnover: 7.195775792038993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7757689339653844
FCF margin (%): 25.129826145856853
Revenue growth (%): 4.395214226041306
Rule of 40 score: 29.525040371898157
Financial ratios for LS4C.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -12384931506.849316
Buffett classification: The Gruesome
Shares outstanding: 486909949
Book value: 31809589041.095825
Debt to equity: 0.32350027991903946
Retained earnings: 2193150684.931507
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MARPS — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.22
Shares outstanding: 2000000
Market cap (USD): 6440000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MARPS — annual report dated 2022-06-30
Total revenue: 1441388
Operating income: 1203641
Net income: 1204193
Capital expenditures: 0
Net tangible assets: 1154143
Owner earnings: 1204193
Return on net tangible assets (%): 104.33655101664179
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.32
P/E ratio: 8.835792933524775
Shares outstanding: 2000000
Book value: 1154143
P/B ratio: 9.218961601811909
Market cap (USD): 10640000
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 16.49430965153033
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 104.28872332111358
Rule of 40 score: 0
Financial ratios for MARPS — annual report dated 2023-06-30
Total revenue: 1609882
Operating income: 1336356
Net income: 1375417
Capital expenditures: 0
Net tangible assets: 978183
Owner earnings: 1375417
Return on net tangible assets (%): 140.6093747284506
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.14
P/E ratio: 6.019992482279919
Shares outstanding: 2000000
Book value: 978183
P/B ratio: 8.464673788033526
Market cap (USD): 8279999.999999999
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 16.990437808485343
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 136.6161546459098
Revenue growth (%): 11.689704645799743
Rule of 40 score: 11.689704645799743
Financial ratios for MARPS — annual report dated 2024-06-30
Total revenue: 994142
Operating income: 662310
Net income: 713165
Capital expenditures: 0
Net tangible assets: 965220
Owner earnings: 713165
Return on net tangible assets (%): 73.88626427135783
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.35
P/E ratio: 9.394740347605392
Shares outstanding: 2000000
Book value: 965220
P/B ratio: 6.941422680839602
Market cap (USD): 6700000
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 33.37873261566255
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 68.61751724995338
Revenue growth (%): -38.247523731552995
Rule of 40 score: -38.247523731552995
Financial ratios for MARPS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.48
Shares outstanding: 2000000
Market cap (USD): 6960000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MARPS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 2000000
Market cap (USD): 7080000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MARPS — quarterly report dated 2025-03-31
Total revenue: 332993
Operating income: 237323
Net income: 242418
Capital expenditures: 0
Net tangible assets: 972606
Owner earnings: 242418
Return on net tangible assets (%): 24.924584055619643
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.54
P/E ratio: 7.30143801202881
Shares outstanding: 2000000
Book value: 972606
P/B ratio: 7.279412218308339
Market cap (USD): 7080000
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 28.73033367067776
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.400733698949008
Rule of 40 score: 0
Financial ratios for MARPS — annual report dated 2025-06-30
Total revenue: 1011104
Operating income: 695269
Net income: 727995
Capital expenditures: 0
Net tangible assets: 921527
Owner earnings: 727995
Return on net tangible assets (%): 78.99877051893216
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.24
P/E ratio: 11.648431651316288
Shares outstanding: 2000000
Book value: 921527
P/B ratio: 9.202117789278015
Market cap (USD): 8480000
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 31.236648257745987
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 75.44749095794263
Revenue growth (%): 1.7061948896636498
Rule of 40 score: 1.7061948896636498
Financial ratios for MARPS — quarterly report dated 2025-06-30
Total revenue: 232550
Operating income: 165788
Net income: 170887
Capital expenditures: 0
Net tangible assets: 921527
Owner earnings: 170887
Return on net tangible assets (%): 18.543895078494714
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.24
P/E ratio: 20.51753547622216
Shares outstanding: 2000000
Book value: 921527
P/B ratio: 9.202117789278015
Market cap (USD): 8480000
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 28.708664803268114
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.990574340198386
Revenue growth (%): -30.1636971347746
Rule of 40 score: -30.1636971347746
Financial ratios for MARPS — quarterly report dated 2025-09-30
Total revenue: 218526
Operating income: 125937
Net income: 130813
Capital expenditures: 0
Net tangible assets: 916146
Owner earnings: 130813
Return on net tangible assets (%): 14.278619346698015
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.55
P/E ratio: 16.724313476120987
Shares outstanding: 2000000
Book value: 916146
P/B ratio: 9.932914622778465
Market cap (USD): 9100000
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 42.36978666154142
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.746389767569797
Revenue growth (%): -6.0305310685874005
Rule of 40 score: -6.0305310685874005
Financial ratios for MARPS — quarterly report dated 2025-12-31
Total revenue: 263371
Operating income: 187036
Net income: 191844
Capital expenditures: 0
Net tangible assets: 1009718
Owner earnings: 191844
Return on net tangible assets (%): 18.999760329121596
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.98
P/E ratio: 10.815775814512163
Shares outstanding: 2000000
Book value: 1009718
P/B ratio: 7.883389223525778
Market cap (USD): 7960000
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 28.983828895360535
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.52358777401215
Revenue growth (%): 20.521585532156355
Rule of 40 score: 20.521585532156355
Financial ratios for MGMA.V — annual report dated 2021-12-31
Capital expenditures: 81018.89763779528
Buffett classification: The Gruesome
Stock price: 1.574803149606299
Shares outstanding: 83475796
Market cap (USD): 131457946.4566929
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGMA.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -606428.6764705882
Net income: -878308.0882352941
Capital expenditures: 86757.35294117646
Operating cash flow: -344452.2058823529
Net tangible assets: -114656.61764705881
Owner earnings: -965065.4411764706
Buffett classification: The Gruesome
Stock price: 1.0588235294117645
Shares outstanding: 83475796
Book value: -114656.61764705881
Market cap (USD): 88386136.94117646
Debt to equity: 0
Current ratio: 0.375711134331824
Quick ratio: 0.375711134331824
Free cash flow (dilution-adjusted): -499522.79411764705
Buyback yield (%): 0
Retained earnings: -20881334.55882353
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGMA.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -572700.7575757576
Net income: -573283.3333333333
Capital expenditures: 0
Operating cash flow: -77268.18181818181
Net tangible assets: -514971.96969696967
Owner earnings: -573283.3333333333
Buffett classification: The Gruesome
Stock price: 0.06060606060606061
Shares outstanding: 83475796
Book value: -514971.96969696967
Market cap (USD): 5059139.151515151
Debt to equity: -0.031505098100367335
Current ratio: 0.011541369783335758
Quick ratio: 0.011541369783335758
Interest coverage ratio: -710.4934210526317
Free cash flow (dilution-adjusted): -86603.03030303029
Buyback yield (%): 0
Retained earnings: -22087385.606060605
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGMA.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 83475796
Market cap (USD): 4946713.837037036
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGMA.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07692307692307693
Shares outstanding: 83475796
Market cap (USD): 6421215.076923077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0